You.Me.We can beat cancer. our people are our strength CARIF milestones
why should I care about cancer? our partners thank you to our donors
how CARIF can make a difference research directions join our efforts

Each of us probably knows of someone who fought cancer, whose courage in battling the disease brings home to all of us the urgency for finding ways of treating and preventing cancer.

In Malaysia, more than 21,000 are diagnosed with cancer every year and it is expected that more people will die of cancer than of heart disease and infectious diseases within the next 10 years.

The World Health Organisation projects that cancer will kill more people in developing countries than in developed countries by the year 2020: it is expected that 75 percent of all cancer deaths worldwide will occur in developing countries. This is, in part, because many developing countries have poor tobacco control policies, many societies are adopting lifestyles which increase their risk, and many developing countries have little resources to detect and treat cancers effectively.

We can and need to do more to ensure that we reduce the risk to cancer through changes in our lifestyles. Half of all cancers could be prevented if we stop smoking, maintain a healthy weight through exercise and a balanced diet. Unfortunately, the number of smokers in Malaysia is increasing, and many more Malaysians are becoming obese.

 

We can and need to do more to ensure that cancers are treated quickly and effectively. The earlier cancer is treated, the more likely the treatment will be successful. Unfortunately, the majority of cancers in Malaysia are detected at a late stage, at least partly because of a lack of awareness of screening and partly because of a lack of proven diagnostic methods for some cancers. Tragically, even when cancers are detected early, they are left untreated or treated with unproven therapies.

We can and need to do more to ensure that future generations have more affordable and effective tools to beat cancer. The world research community and industry is developing more precisely-targeted forms of chemotherapy, but sadly, the average Malaysian cannot afford the majority of these therapies. In addition, the majority of these therapies are developed for cancers which are common among Caucasians, but these therapies have not yet been developed for cancers which are common among Asians.

Home Contact Us

Career Opportunities

Copyright @ 2010 CARIF Malaysia.